Medrain Pharmaceuticals Private Limited

Medrain Pharmaceuticals Private Limited - pharma in Nagaon, Assam, India. FY 2026 financials & compliance.
CIN U74999AS2017PTC017825 Incorporated 03 March 2017 ROC Guwahati HQ Nagaon, Assam, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2022
₹4.91 Lakh
▼ 68% YoY
Net profit · FY 2022
₹3,415
Net margin 0.7%
EBITDA · FY 2022
₹1.31 Lakh
EBITDA margin 26.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Medrain Pharmaceuticals Private Limited

Data last updated:

Medrain Pharmaceuticals Private Limited is a private limited company based in Nagaon, Assam, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 March 2017 and has been in existence for over 9 years.

The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U74999AS2017PTC017825. Its GSTIN is 18AAKCM8819L1ZP (Assam).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Jui Rani Paul and Partha Saha.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Nagaon, Assam.

As per the financials filed for FY 2022, the company reported a revenue of ₹4.91 Lakh, a decline of 68% compared to the previous year. For the same year it recorded a net profit of ₹3,415 (net margin 0.7%) and EBITDA of ₹1.31 Lakh (EBITDA margin 26.8%). Revenue has declined at a compounded annual rate (CAGR) of 38% over three years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U74999AS2017PTC017825
Registration Number 017825
Incorporation Date 03 March 2017
ROC Guwahati
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Medrain Pharmaceuticals Private Limited's registered office is in Nagaon, Assam. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    C/O – Majboor Tailor Sankar Dev Path Dhing Road Near Hanuman Mandir Haibar, Gaon, Nagaon, Assam, India – 782002
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Medrain Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Medrain Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Medrain Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Medrain Pharmaceuticals Private Limited, buy the company report.

Financials of Medrain Pharmaceuticals Private Limited

FY 2025 filings available

Medrain Pharmaceuticals Private Limited reported revenue of ₹4.91 Lakh (down 68% YoY) for FY 2022.

Revenue · FY 2022
₹4.91 Lakh ▼ 68%
Net profit · FY 2022
₹3,415 margin 0.7%
EBITDA · FY 2022
₹1.31 Lakh margin 26.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 68%
3 years · compounded
▼ 38%
EBITDA CAGR growth
1 year
▲ 20%
3 years · compounded
▲ 172%

Revenue has declined at a compounded annual rate (CAGR) of 38% over three years, including a 68% fall in the latest year. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profit and Loss Statement
Revenue from Operations₹4.91 Lakh
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.31 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹3,415
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profitability
EBITDA Margin26.8%
Net Profit Margin0.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Medrain Pharmaceuticals Private Limited, buy the company report.

Board of directors of Medrain Pharmaceuticals Private Limited

Medrain Pharmaceuticals has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Jui Rani PaulDirector03 Mar 20179 Years 7 MonthsCurrent
Partha SahaDirector31 Oct 20187 Years 11 MonthsCurrent
Albert SahaDirector31 Oct 20187 Years 11 MonthsCurrent

Auditor

Medrain Pharmaceuticals Private Limited is audited by GUPTA ANKIT & CO for the financial year 2020.

Auditor firmFinancial yearFirm registration number
GUPTA ANKIT & COFY 2020022925N

Shareholding

The shareholding of Medrain Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2020, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Medrain Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Medrain Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Medrain Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
18AAKCM8819L1ZPAssamActive15 Jul 2017

To see the full GST registrations and return filing status of Medrain Pharmaceuticals Private Limited, buy the company report.

Recent activity

Medrain Pharmaceuticals Private Limited has 8 board changes on record since 2017: 3 appointments and 5 cessations. The latest: Albert Saha ceased to be Additional Director on 30 Sep 2019.

AGM
Medrain Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Medrain Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Guwahati.
Ceased
Albert Saha ceased to be Additional Director.
Ceased
Partha Saha ceased to be Additional Director.
Ceased
Rupam Nath ceased to be Director.
Appointed
Albert Saha was appointed as Director.
Appointed
Partha Saha was appointed as Director.
Ceased
Indrani Sarkar Das ceased to be Director.
Ceased
Suchitra Devi ceased to be Additional Director.
Appointed
Jui Rani Paul was appointed as Director.
Incorporation
03 Mar 2017
Medrain Pharmaceuticals Private Limited was registered on 03 Mar 2017 with Roc Guwahati & aged 9 years 7 months as per MCA records.

Frequently asked questions

Medrain Pharmaceuticals is an active private limited company based in Nagaon, Assam, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 March 2017 (9+ years old) and is registered under CIN U74999AS2017PTC017825.

Medrain Pharmaceuticals has 3 current directors:

The latest financial statements of Medrain Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.

The GSTIN of Medrain Pharmaceuticals is 18AAKCM8819L1ZP, registered in Assam.

The CIN (Corporate Identification Number) of Medrain Pharmaceuticals is U74999AS2017PTC017825. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Medrain Pharmaceuticals was incorporated on 03 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Guwahati.

Albert Saha ceased to be Additional Director on 30 Sep 2019. Partha Saha ceased to be Additional Director on 30 Sep 2019. Rupam Nath ceased to be Director on 05 Mar 2019. Medrain Pharmaceuticals has 8 board changes on record in total.

The registered office of Medrain Pharmaceuticals is at CO – Majboor Tailor Sankar Dev Path Dhing Road Near Hanuman Mandir Haibar, Gaon, Nagaon, Assam, India – 782002.

Medrain Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

The compliance status of Medrain Pharmaceuticals is compliant as of 28 September 2026. The company is actively filing with the Registrar of Companies.